WO2009138881A2 - Method and system for monitoring a health condition - Google Patents

Method and system for monitoring a health condition Download PDF

Info

Publication number
WO2009138881A2
WO2009138881A2 PCT/IB2009/006081 IB2009006081W WO2009138881A2 WO 2009138881 A2 WO2009138881 A2 WO 2009138881A2 IB 2009006081 W IB2009006081 W IB 2009006081W WO 2009138881 A2 WO2009138881 A2 WO 2009138881A2
Authority
WO
WIPO (PCT)
Prior art keywords
monitoring device
monitoring
patient
computing device
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/006081
Other languages
English (en)
French (fr)
Other versions
WO2009138881A4 (en
WO2009138881A3 (en
Inventor
Dan Gur Furman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardio Art Technologies Ltd
Original Assignee
Cardio Art Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/119,325 external-priority patent/US8298148B2/en
Priority claimed from US12/206,885 external-priority patent/US20090048518A1/en
Priority to CN2009801189249A priority Critical patent/CN102046069A/zh
Application filed by Cardio Art Technologies Ltd filed Critical Cardio Art Technologies Ltd
Priority to JP2011509040A priority patent/JP5650104B2/ja
Priority to EP09746176A priority patent/EP2282667A4/en
Priority to CA2722616A priority patent/CA2722616A1/en
Publication of WO2009138881A2 publication Critical patent/WO2009138881A2/en
Publication of WO2009138881A3 publication Critical patent/WO2009138881A3/en
Publication of WO2009138881A4 publication Critical patent/WO2009138881A4/en
Priority to IL209210A priority patent/IL209210A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/489Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/04Measuring blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4483Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer
    • A61B8/4494Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer characterised by the arrangement of the transducer elements

Definitions

  • the present invention relates to health monitoring systems and methods and, more specifically, to systems and methods including devices for monitoring cardiac behaviour.
  • Cardiovascular disease is a large, growing health problem world wide. Some studies indicate that approximately 15% of the Western World suffers from one or more cardiovascular disease. In the United States, nearly 25% of the population is affected, resulting in more than six million hospitalizations every year.
  • in vivo parameters of a patient may need to be monitored over a period of time.
  • Heart arrhythmias are changes in the normal sequence of electrical impulses that cause the heart to pump blood through the body. Continuous monitoring may be required to detect arrhythmias because abnormal heart impulse changes might only occur sporadically. With continuous monitoring, medical personnel can characterize cardiac conditions and establish a proper course of treatment.
  • This device comprises an implantable heart monitor used, for example, in determining if syncope (fainting) in a patient is related to a heart rhythm problem.
  • the Reveal monitor continuously monitors the rate and rhythm of the heart for up to 14 months.
  • the patient After waking from a fainting episode, the patient places a recording device external to the skin over the implanted Reveal monitor and presses a button to transfer data from the monitor to the recording device.
  • the recording device is provided to a physician who analyzes the information stored therein to determine whether abnormal heart rhythm has been recorded.
  • the use of the recording device is neither automatic nor autonomic, and therefore requires either the patient to be conscious or another person's intervention to transfer the information from the monitor to the recording device.
  • transponder-type device in which a transponder is implanted in a patient and is subsequently accessed with a hand-held electromagnetic reader in a non-invasive manner.
  • An example of the latter type of device is described in U.S. Pat. No. 5,833,603.
  • medical personnel are interested in collecting a variety of different types of data relating to the behaviour of the heart and the condition of the patient.
  • HCP health care provider
  • Relevant information may include the oxygen saturation level of blood flowing through the aorta, blood pressure, heart rate, blood flow, stroke volume, cardiac output, the electrical activity of the heart (for generating electrocardiogram (ECG) data), and body temperature.
  • the system includes a monitoring device, a patient monitoring application, and a data store.
  • the monitoring device includes a Doppler sensor, an optical sensor, and a computing device.
  • the sensors and the computing device are enclosed in a housing.
  • the patient monitoring application receives parameter values from the monitoring application and stores them in the data store.
  • a method for monitoring a health condition includes the steps of providing a monitoring device as described in the paragraph immediately above and computing one or more hemodynamic parameters with the monitoring device. The method further includes the steps of diagnosing a health condition based on the hemodynamic parameters and performing a function responsive to the health condition.
  • the method for monitoring a health condition includes the steps of providing a monitoring device as described above and further including a communication device. The method further includes the steps of transmitting a command to the monitoring device and performing a function responsive to the command.
  • Figures 1 and 2 are schematic views of a system according to one embodiment of the present invention.
  • Figure 3 is a schematic side view of a monitoring device according to one embodiment of the present invention.
  • Figure 4 is a conceptual view of a computing device according to one embodiment of the present invention.
  • Figures 5 and 6 are a conceptual representations of protocols for performing embodiments of a method according to the invention.
  • Figure 7 is a flow-chart of a further embodiment of a method according to the invention.
  • Figs. 1 and 2 illustrate a system according to one embodiment of the invention.
  • System 100 comprises a monitoring device 1 positioned on a patient 102, and an external communication device 120, exemplified as a personal digital assistant or Blackberry device.
  • External communication devices may be any devices capable of receiving wireless or internet communications, such as communication devices 1 10, 132, and 142, exemplified as a relay unit, phone, and computer, respectively.
  • Communication devices 120 and 132 and, optionally, 1 10, transfer information wirelessly through telecommunication network 130.
  • Communication device 110 may also include a Bluetooth adapter or another adapter for communicating wirelessly with monitoring device 1 without using telecommunication network 130.
  • Telecommunication network 130 is operably connected to the internet, represented by numeral 140, which transfers information from the telecommunication network to communication device 142.
  • system 100 further includes a website (not shown) containing webpages and residing in a server 144.
  • system 100 also includes a cardiac device 150 adapted to provide a treatment to the heart of patient 102.
  • System 100 includes a patient management application 200 and a data store 210.
  • Patient management application 200 is a program configured to receive data from monitoring device 1 and other computing devices and to store data in data store 210.
  • Patient management application 200 may reside in server 144.
  • Patient management application 200 may be a client/server application with client programs residing in communication devices accessible through the internet.
  • Data store 210 stores data pertaining to patients 102.
  • Data may include a patient profile 212 including patient information such as, for example, address, insurance information, contact information, and device identification information for associating patient 102 with a specific monitoring device 1 and for enabling access to the sensing device.
  • Data may also include values 214 comprising reference, measurement and parameter values retrieved from an associated monitoring device 1.
  • Patient management application 200 may display values in a variety of ways to assist the HCP in managing the patient's health.
  • Data may also include protocols 216.
  • Patient management application 200 has many functions. It retrieves data from monitoring device 1. It also updates reference values and protocols. It also transmits commands to monitoring device 1. In one embodiment, patient management application 200 sends commands to monitoring device 1 and monitoring device 1 performs functions responsive to the commands. In another embodiment, an HCP uses an external communication device to communicate with client management application 200 and client management application 200 communicates with monitoring device 1 responsive to the HCP communications. In another embodiment, an HCP accesses patient management application 200 through a website accessible via the internet.
  • Fig. 3 depicts monitoring device 1 including, generally, a plurality of components.
  • Monitoring device 1 may include a computing device 20, a communication device 30, an energy storage device 40, an optical sensor assembly 2, an ECG sensor including probes 5OA and 5OB (hereinafter collectively referred to as ECG sensor 50), a Doppler sensor 60, and a temperature sensor 70, each of the components mounted on a board 80 and being in electronic communication with computing device 20.
  • the components are enclosed in a housing 90.
  • System 100 operably connects monitoring device 1 with one or more communication devices adapted to exchange data with monitoring device 1.
  • Data includes commands, measurement, parameter and reference values, and protocols.
  • Monitoring device 1 acquires measurement values, processes them according to a protocol, which in many cases involves comparing them to reference values and diagnostic profiles to diagnose abnormal conditions, and then performs a function according to a response profile based on the diagnosis.
  • Commands are instructions provided from an external communication device to computing device 20. Generally, commands are instructions for performing a function.
  • Functions include transmitting data, performing a treatment, updating reference values, and updating protocols.
  • Reference values represent a normal or stable condition of a patient.
  • Monitoring device 1 may be programmed with reference values or may be programmed to collect measurements upon placement of the device on patient 102 and to store the initial measurements or parameters as reference values.
  • parameter values include hemodynamic parameters such as pulse rate, oxygen saturation, cardiac output, and blood pressure, and also temperature.
  • Reference values may include target values and acceptable variation ranges or limits. Parameter values may indicate an abnormality when they fall outside reference target values or ranges. In some embodiments, parameter values may produce a statistic such as, for example, a moving average, and an abnormality would be detected when the parametric statistic differs from a reference statistic by more than an expected amount.
  • One abnormal medical condition is cardiac arrhythmia.
  • Computing device 20 may be configured to perform an analysis of the measurement values to determine, for example, whether the cardiac rhythm is irregular indicating arrhythmia.
  • Other abnormal conditions include low oxygen saturation, low cardiac output, and high or low blood pressure.
  • Other abnormal conditions may depend on combinations of various hemodynamic parameter values.
  • Protocols include diagnostic and response profiles. Diagnostic profiles provide computing device 20 decision criteria for diagnosing abnormal conditions. Response profiles provide computing device 20 instructions for performing functions responsive to diagnosis. Initially, one or more protocols may be programmed into monitoring device 1. A response profile in a first protocol may instruct computing device 20 to switch to a second protocol in response to an abnormal condition. In one embodiment, protocols may be downloaded to computing device 20 through communication device 30.
  • references made to monitoring device 1 refer to the monitoring device 1 described in the Integrated Device application incorporated herein by reference above.
  • references made to optical sensor assembly 2 refer to the optical sensor assembly 2 described in the Optical Sensor Apparatus application incorporated herein by reference above.
  • references to the Doppler sensor 60 refer to the Doppler sensor 60 described in the Doppler Motion Sensor application incorporated by reference above. The full description of the monitoring device 1 , optical sensor assembly 2 and Doppler sensor 60 will not be repeated in this application.
  • communication signal is meant a signal that has one or more of its characteristics set or changed to encode information in the signal.
  • communication signals include acoustic, RF, infrared, other wireless media, and combinations of any of the above.
  • Relay unit 110 is located externally of the patient's body, e.g. clipped to the patient's belt.
  • Relay unit 1 10 may include a receiver for receiving the transmissions from communication device 30, and a transmitter for re-transmitting the communication signal to another external communication device.
  • Relay unit 1 10 may also be stationary and hardwired for connection to the internet or direct connection to a healthcare provider's computer.
  • relay unit 1 10 may receive a communication signal from a healthcare provider and transmit the signal to communication device 30.
  • Optical sensor assembly 2 includes a plurality of photon emitters and a plurality of photon detectors for detecting a plurality of optical signals.
  • the emitters and detectors face the aorta.
  • Computing device 20 operates the plurality of emitters and detectors and processes the plurality of optical signals to obtain optical measurement values representing the location and size of the aorta and the oxygen saturation of the blood flowing through the aorta.
  • Doppler sensor 60 emits and detects a plurality of ultrasonic waves.
  • Computing device 20 also operates Doppler sensor 60 and, with the aid of the optical measurement values obtained using optical sensor assembly 2, processes the plurality of ultrasonic waves to obtain Doppler measurement values representing heart rate, blood flow, stroke volume, blood pressure, and cardiac output.
  • ECG sensor 50 detects the electrical signals which cause the heart to pump.
  • Temperature sensor 70 measures the temperature of the patient.
  • Energy storage device 40 powers computing device 20, the various sensors, and communication device 30 which is configured to transmit the collected data, or information relating to the collected data, according to various embodiments of a method disclosed herein.
  • the sensors, computing device 20, communication device 30, and energy storage device 40 are enclosed in a housing 90. Integrating the plurality of sensors and other components mentioned above in monitoring device 1 permits a single device, mounted at one location on the patient's body, to accurately measure a comprehensive set of parameters relating to the behaviour of the heart, including cardiac output.
  • monitoring device 1 may perform analyses of the parameters and perform functions in response to the "on-board" analyses, as opposed to other sensing devices that export raw data for analysis by another device. As indicated above, monitoring device 1 also communicates with other devices, wirelessly or otherwise, providing information and receiving commands and data. As such, monitoring device 1 collects, analyzes, and communicates data without any human intervention.
  • monitoring device 1 is implanted subcutaneously in the patient's body. It should be understood, however, that monitoring device 1 may be implanted at different locations using various implantation techniques. For example, monitoring device 1 may be implanted within the chest cavity beneath the rib cage. Housing 90 may be formed in the shape of a circular or oval disc, with dimensions roughly the same as two stacked quarter dollar coins. More specifically, housing 90 may be approximately three centimetres in diameter and approximately one centimetre thick. Of course, housing 90 may be configured in a variety of other shapes and sizes, depending upon the application.
  • Monitoring device 1 may be integrated with an implanted cardiac device 150 such as a pacemaker, a Cardiac Resynchronization Therapy (CRT) device, an implantable cardioverter defibrillator (ICD), etc.
  • an implanted cardiac device 150 such as a pacemaker, a Cardiac Resynchronization Therapy (CRT) device, an implantable cardioverter defibrillator (ICD), etc.
  • monitoring device 1 may communicate with the implanted cardiac device and provide information from the implanted cardiac device as well as from its own sensors to external devices. As many implanted cardiac devices are currently well- understood and routinely prescribed, integration of monitoring device 1 into such other devices may provide an effective means for achieving market acceptance.
  • monitoring device 1 may be positioned externally to the patient's body.
  • a support member is provided to support monitoring device 1 externally to the body.
  • the support member may be permanently or temporarily coupled to monitoring device 1.
  • the support member may comprise an adhesive layer for adhesively coupling the support member to the patient's body or may comprise a belt, which may be elastic, for holding monitoring device 1 against the patient's body.
  • Monitoring device 1 may be implanted or positioned on the patient with the aid of an external mapping system such as an ultrasound machine. Proper placement ensures that a vessel of interest, e.g. the aorta, is located within the sensing range of the various sensors of monitoring device 1. For example, monitoring device 1 may be positioned on the chest or back of the patient in a location that reduces interference by the ribs of the measurements acquired in the manner described herein.
  • an external mapping system such as an ultrasound machine.
  • Computing device 20 comprises a plurality of components. While components are described herein as if they were independent components, the components may be combined in a single device such as an application specific integrated circuit. As shown in Fig. 4, computing device 20 includes an A/D converter 22 (which also converts optical signals to digital signals), a processor 24, a memory 26, a program 28, a data 29, inputs 23, and outputs 25. Memory 26 may include, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology. A/D converter 22, processor 24 and memory 26 may be constructed in an integrated circuit. The integrated circuit may further include emitter array 100, detector array 200, and communication device 30.
  • Program 28 represents computer instructions directing processor 24 to perform tasks responsive to data 29.
  • Program 28 resides in memory 26.
  • Data 29 includes values and protocols and also resides in memory 26.
  • Reference data may be stored in ROM or it may be stored in RAM so that it may be modified over time, either in response to external inputs or in response to characteristics of measurement data collected over time. Protocols for responding to measurement values may also be provided. Protocols may be stored in permanent memory or may be stored in non-permanent memory such as RAM.
  • Computing device 20 may be configured to cause communication device 30 to transmit an alert if an abnormal condition is detected, particularly a condition determined to be a serious or dangerous condition.
  • a diagnosis profile in an active protocol provides criteria to determine whether a condition is normal or abnormal, and if abnormal, the degree of severity.
  • a response profile in the protocol provides criteria to respond to the diagnosis. Transmission of an alert is one example of a response.
  • the alert may be used to actuate an alarm or to alert the patient to take remedial action.
  • a remedial action may be terminating or reducing physical activity.
  • the alert may also provide global positioning (GPS) information to an emergency service.
  • GPS global positioning
  • the abnormal condition when found to be present, may also be displayed on external communication devices 110, 120, 132 and or 142.
  • the alert may comprise a text message or a code corresponding to the condition.
  • computing device 20 may also initiate a new measurement cycle and measure on a continuous basis in response to the detection of an abnormal condition.
  • Computing device 20 may also initiate a treatment according to a response profile or responsive to a command.
  • Monitoring device 1 may receive, through communication device 30, an external command to perform a treatment in response to the alert.
  • an abnormal condition may also be used to direct a device adapted to provide treatment to deliver such treatment.
  • Treatment may include, for example, an electric shock or a drug delivery. Parameter values and/or other information may be communicated to an external device.
  • the parameter values may be stored in memory 26 and transmitted wirelessly by communication device 30.
  • the communication signal from communication device 30 may be activated on a periodic basis (e.g., once per day, once per week, etc.), in response to an abnormal condition, in response to an externally received command, whenever memory usage exceeds a predetermined amount, or whenever the energy storage level is determined to be low, the latter two conditions established to prevent data loss as a result of memory overflow or energy loss.
  • monitoring device 1 may include communication devices in addition to communication device 30. For example, where communication device 30 is a cellular modem, monitoring device 1 may also include a backup Bluetooth or RF communication device.
  • Such a backup device may be desirable in situations where, after one or more attempts, it becomes apparent that the cellular modem is unable to transmit information (e.g., due to low available power, poor network coverage, etc.). In such a situation, computing device 20 may activate the backup communication device to transmit information or an alert to an alternate external communication device.
  • computing device 20 may be programmed to respond to requests for data received by communication device 30 (e.g., from a health care provider) by causing communication device 30 to transmit the requested data or information representing the requested data.
  • requests for data received by communication device 30 e.g., from a health care provider
  • the communication signal may be received by equipment near the patient to alert the patient to the condition, or received remotely (such as over a network) by a healthcare provider, relative, or other predetermined recipient.
  • each of or some of optical sensor assembly 2, Doppler sensor 60, ECG sensor 50, and temperature sensor 70 may be modular in design.
  • a plurality of different Doppler sensors 60 may be produced to have different performance characteristics (e.g., different output frequencies).
  • any of the plurality of the sensors may be installed in monitoring device 1 to achieve the desired performance.
  • computing device 20 may be programmed to adapt the various algorithms to accommodate the selected sensors.
  • a basic monitoring device 1 including computing device 20, communication device 30, etc., may be "custom" built with any of a variety of sensors and programmed to operate with the selected sensors. It should be understood that while optical sensor assembly 2, Doppler sensor 60, and temperature sensor 70 are described herein as being activated to obtain measurements relatively infrequently (at least under normal conditions) to conserve power, as battery technology improves, the frequency of activation of these sensors may be increased. Also, where monitoring device 1 is worn externally, connector 85 may be used to supply power to sensing device 85, thereby eliminating the power consumption concern and permitting frequent, or even continuous, operation of these sensors. Furthermore, connector 85 may be utilized to operably connect other sensors to monitoring device 1.
  • communication device 30 is a two-way communication device, e.g. via the cellular telephone system and/or the GPS satellite system, such as NOKIA model number KNL1 147-V.
  • communication device 30 is capable of transmitting information, but does not receive information or commands.
  • a system for recharging energy storage device 40 may be provided in one embodiment according to the invention.
  • Computing device 20 receives energy from energy storage device 40.
  • Energy storage device 40 includes an energy storage component such as a battery.
  • monitoring device 1 may also include an energy coupler for receiving energy from an external source to charge energy storage device 40.
  • an energy coupler is an electromagnetic device, such as induction coils, for receiving external electromagnetic signals and converting them into electrical energy for recharging the energy storage component.
  • An external electromagnetic device generates electromagnetic signals which are received and converted into electrical energy by energy storage device 40.
  • Energy storage device 40 may provide a charge signal to computing device 20.
  • Computing device 20 may compare the charge signal to a reference charge signal and initiate a low charge communication signal for alerting the patient and/or healthcare providers.
  • a detector such as a voltage sensor, may be used to monitor the charge of energy storage device 40 and provide a signal to computing device 20 when the charge falls below a threshold.
  • the electromagnetic device may be placed near monitoring device 1 to charge energy storage device 40. Energy may instead, or additionally, be provided in the form of ultrasonic vibrations.
  • a piezoelectric transducer may be included in monitoring device 1.
  • An ultrasonic vibration may be provided externally.
  • the transducer generates electricity when driven by ultrasonic vibrations.
  • energy or power may also be provided to monitoring device 1 through connector 85.
  • Heart failure can result from any structural or functional cardiac disorder that impairs the ability of the heart to pump a sufficient amount of blood through the body.
  • Heart failure is caused by any condition which reduces the efficiency of the myocardium through damage or overloading, including myocardial infarction (in which the heart muscle is starved of oxygen and becomes damaged) and hypertension (which increases the force of contraction needed to pump blood and often causes the heart muscle to become thicker, resulting in altered function of the muscle).
  • myocardial infarction in which the heart muscle is starved of oxygen and becomes damaged
  • hypertension which increases the force of contraction needed to pump blood and often causes the heart muscle to become thicker, resulting in altered function of the muscle.
  • Heart failure can be chronic and congestive, or decompensated. Decompensated heart failure occurs when a patient with chronic heart failure develops acute symptoms.
  • Symptoms may be based on the side of the heart, right or left, that is involved, the type of failure, either diastolic or systolic, whether the abnormality is due to low cardiac output, and the degree of functional impairment conferred by the abnormality (based on functional classification).
  • Heart changes include reduced contractility, or force of contraction, due to overloading of the ventricle; reduced stroke volume; increased end systolic volume (usually caused by reduced contractility); decreased end diastolic volume (usually caused by impaired ventricular filling); reduced spare capacity; and increased heart rate stimulated by increased sympathetic activity in order to maintain cardiac output.
  • the predominant respiratory symptom of left side failure is shortness of breath on exertion (dyspnea) or at rest, and easy fatigueability. Other symptoms include increasing breathlessness on reclining and severe breathlessness during sleep, usually several hours after going to sleep. Poor circulation to the body leads to dizziness and confusion.
  • the right side of the heart pumps deoxygenated blood and right side failure leads to congestion of peripheral tissues. Heart failure may decompensate easily as a result of intercurrent illness, myocardial infarction, arrhythmias, and uncontrolled hypertension, among other causes.
  • General signs indicating possible heart failure include a laterally displaced apex beat (as the heart is enlarged), a gallop rhythm (additional heart sounds) in case of decompensation, and heart murmurs which may indicate valvular heart disease, either as a cause (e.g. aortic stenosis) or as a result of the heart failure.
  • An echocardiogram may be used to identify these general signs of possible heart failure.
  • Heart failure caused by systolic dysfunction is the failure of the pump function of the heart. It is characterized by a decreased ejection fraction (less than 50%, and often significantly lower). Normally, the ejection fraction should be between 50% and 70%.
  • the strength of ventricular contraction is attenuated and inadequate for creating an adequate stroke volume, resulting in inadequate cardiac output. Because the ventricle is inadequately emptied, ventricular end-diastolic pressure and volumes increase. On the left side of the heart, the increased pressure causes pulmonary edema. On the right side of the heart, the increased pressure results in dependent peripheral edema.
  • Doppler sensor 60 may be used to determine the stroke volume (SV), an important determinant of cardiac function.
  • Heart failure caused by diastolic dysfunction is the failure of the ventricle to adequately relax and typically denotes a stiffer ventricular wall. This causes inadequate filling of the ventricle which results in an inadequate stroke volume.
  • the failure of ventricular relaxation also results in elevated end-diastolic pressures which results in edemas.
  • Diastolic dysfunction may not manifest itself except in physiologic extremes if systolic function is preserved, thus, a patient may be completely asymptomatic at rest.
  • diastolic dysfunction is hypersensitive to increases in heart rate and blood pressure. Sudden bouts of tachycardia can be caused by exertion, fever, or dehydration.
  • ECG sensor 50 may track increases in heart rate by comparing heart rate to reference values. Elevated blood pressures may be identified with Doppler sensor 60 in a similar manner. The parameters may be correlated in time to potentially diagnose diastolic dysfunction.
  • the patient is 65 years old and suffered an anterior myocardial infarction two years prior to the event.
  • the year prior to the event he suffered from congestive heart failure, characterized by dyspnoea on mild effort, fatigue and rare events of shortness of breadth at rest.
  • His New York Heart Association functional class was defined as N-III.
  • He received medications including ACE inhibitors, beta blockers and spironolactone which resulted in some functional improvement.
  • the patient After experiencing general weakness and some shortness of breath, the patient called his HCP and communicated his symptoms.
  • the patient does not benefit from using monitoring device 1.
  • the symptoms would almost certainly lead the HCP to suspect decompensated heart failure.
  • a typical response would be to send a mobile intensive care unit to collect the patient. If decompensated heart failure did not exist, collecting the patient would be unnecessary. However, if decompensated heart failure did exist, and the patient arrived at the healthcare facility more than two or three hours after the event, late treatment may be dangerous and, occasionally, life threatening.
  • the patient does benefit from using monitoring device 1.
  • the HCP programs monitoring device 1 with protocols corresponding to the patient's history and New York Heart Association functional class or another classification. The protocols may be updated from time to time.
  • the HCP upon receiving the phone call the HCP accesses an external communication device to retrieve pulse rate data, through communication device 30, to determine whether any arrhythmia is present. Then, the HCP retrieves O 2 saturation measurements. A normal saturation (>98%) would almost certainly exclude a serious event. To complete the examination, the HCP instructs the patient, by telephone, to sit still for two to three minutes after which time the HCP commands monitoring device 1 to compute cardiac output and blood pressure. This information would be sufficient to determine whether the patient indeed suffers from decompensation. If he does not, an unnecessary trip to the healthcare facility may be avoided.
  • the HCP sends commands to monitoring device 1 using the external communication device.
  • the HCP may select commands from patient management application 200 which may include a website dedicated to support such communications.
  • the external communication device may be phone 132 and the commands may comprise dialing a phone number for accessing communication device 30, in this case a telephone modem, entering a numeric access code for accessing data on monitoring device 1 , and subsequently entering a numeric code corresponding to a protocol for retrieving data.
  • a protocol may refer to a single parameter or to more than one parameter.
  • Monitoring device 1 responds to each command by transmitting a string of data. Referring to Fig. 5, an exemplary group of protocols are illustrated.
  • the HCP activates a protocol A to retrieve pulse and oxygen saturation data.
  • ECG sensor 50 and optical sensor assembly 2 which are low power devices, obtaining these values does not consume much energy.
  • a protocol B may also be activated instructing the patient to rest for two or three minutes.
  • the HCP activates a protocol C to retrieve cardiac output and blood pressure values. These are obtained with the Doppler sensor 60 which consumes more energy than optical sensor assembly 2.
  • the patient may have been resting already and the HCP might not need to wait before activating protocol C.
  • a second scenario exhibiting some automation, upon receiving the phone call the
  • Protocol D accesses an external communication device to activate a diagnosis protocol D.
  • Protocol D may then cause computing device 20 to (a) transmit pulse and oxygen saturation data, (b) wait and send a "wait" message to relay unit 1 10, and (c) transmit cardiac output and blood pressure data.
  • protocol D automates activation of protocols A-C.
  • the HCP may remain on the phone with the patient while transmitting the command to activate protocol D and receiving information on the external communication device. If the patient does not have a relay unit, the HCP may instruct the patient to rest.
  • Relay unit 1 10 may be a communication device capable of transmitting wireless commands to monitoring device 1.
  • relay unit 110 may include a button designated as a "panic" button which a patient or another person may press in case of concern.
  • patient 102 presses the panic button which commands monitoring device 1 to activate a protocol E.
  • Protocol E directs computing device 20 to activate protocol D and to also protocol F to inform the HCP that the panic button was pushed.
  • the HCP may text-message relay unit 110 from a communication device with additional instructions for the patient or may take other discretionary actions. Protocol E saves the time required for the patient to call the HCP and for the HCP to activate protocol D.
  • monitoring device 1 diagnoses an abnormality and performs a function according to a protocol F.
  • a diagnosis profile in monitoring device 1 directs the device to monitor, at predetermined time intervals, changes in cardiac pulse rate, cardiac output, oxygen saturation, or combinations of changes in these parameters. The profile also directs the device to compare the changes to reference values and to signal an abnormal condition if the changes exceed a predefined amounts.
  • a response profile directs the device to perform a function responsive to the abnormality.
  • monitoring device 1 sends a message or data to the HCP if values differ from reference values within a range.
  • monitoring device 1 sends an alarm to the HCP if values differ by more than a range, signifying an emergency.
  • the alarm may also be sent to designated caretakers of the patient, or may even send an alarm to a healthcare facility, ambulance service or fire department.
  • monitoring device 1 may send a message to relay unit 1 10 which patient 102 may read.
  • the relay unit may display a message instructing the patient to sit, rest, drink water, etc.
  • a 60 year old patient experiences an event 2 weeks after coronary bypass surgery. He has been well, already walking 45 minutes/day and starting to do some office work from home. He experiences palpitation, some shortness of breath and dizziness. The symptoms may be due to atrial flutter/fibrillation which is a common condition during the first several weeks after bypass surgery.
  • Diagnosis in this case requires pulse, blood saturation, blood pressure and cardiac output data. If the data appears normal compared to reference values, the patient is instructed to rest and the heart parameters are checked again in one to two hours. The second check may be performed by the HCP without requiring a phone call to contact the patient. If all parameters are stable and the patient feels better - he can stay home.
  • a patient has an implanted ICD (defibrillator). After waking up from an afternoon nap, the patient is somewhat confused and has some chest discomfort. He is concerned that the ICD may have charged and that he may have had a serious arrhythmia.
  • ICD implanted ICD
  • monitoring device 1 is incorporated, either integrated or operably connected, into the ICD. If the ICD determines that defibrillation is appropriate, the ICD communicates the determination to monitoring device 1. Monitoring device 1 checks hemodynamic parameters (pulse, oxygen saturation, blood pressure, cardiac output) and verifies an abnormality indicating that defibrillation is appropriate or determines that it is not. If the latter, monitoring device 1 instructs the ICD to not charge. Monitoring device 1 might also transmit the event information to the HCP. The HCP could interrogate the device to collect the hemodynamic parameters and to determine whether an arrhythmia had indeed occurred. If no arrhythmia was detected and hemodynamic parameters are normal, no further investigation is necessary. In another scenario, monitoring device 1 is not incorporated into the ICD.
  • hemodynamic parameters pulse, oxygen saturation, blood pressure, cardiac output
  • Monitoring device 1 may be programmed to detect when the ICD charges.
  • the patient may initiate communication with the HCP by telephone, panic button, or any other means described above to determine whether the ICD charged.
  • the charge event is displayed in relay unit 110 for the patient to read.
  • other cardiac devices are operationally integrated with monitoring device 1 to improve their joint performance by combining features.
  • Fig. 7 illustrates an embodiment of a patient management method according to one embodiment of the invention.
  • an HCP sets up monitoring device 1 for use with patient 102.
  • the HCP populates data store 210 with information relating to patient 102 including patient history, monitoring device identification, and other information.
  • the HCP also selects protocols to download to monitoring device 1. Protocols may be downloaded using connector 85 while monitoring device 1 is docked in a docking station. Monitoring device 1 is positioned on the patient with the aid of an ultrasound machine.
  • the HCP may obtain baseline measurements and may store the measurements as reference values in computing device 20.
  • monitoring device 1 monitors patient 102. Monitoring may be performed according to protocol F as described above or according to another protocol. Monitoring includes activating sensors to obtain measurement values, computing parameter values, comparing the values to reference values according to a protocol, and diagnosing a normal or abnormal condition. If values are outside a reference range, monitoring device 1 may proceed to step 712 or may initiate a new measurement cycle to verify the parametric data before diagnosing an abnormality. Otherwise, monitoring device 1 proceeds to step 720 and then returns to step 700.
  • monitoring device 1 receives a command from an external communication device. A command may direct monitoring device 1 to transmit parameter values according to a protocol, or update a protocol, or update a program.
  • monitoring device activates a protocol.
  • the protocol may indicate which parameters to sense, how much data (minutes, hours, days) to acquire, and how frequently to continue measuring.
  • the protocol is determined by the command received or responsive to the monitoring protocol from step 700.
  • the external communication device may be computer 142.
  • Computer 142 may include patient management application 200 or may access patient management application 200 through the internet.
  • Patient management application 200 may provide an option menu showing available protocols and may also include security features for the protection of the patient's privacy as well as well-being.
  • the external communication device may also be communication device 110, 120 and 132.
  • monitoring device 1 activates the sensors which generate signals that are received by computing device 20.
  • Computing device 20 conditions the signals and converts them to measurements, then analyzes the measurements and computes parameter values.
  • computing device 20 performs additional instructions provided in the protocol.
  • the communication device accesses monitoring device 1 directly without using a patient management application.
  • the communication device may dial monitoring device 1 and provide commands via a keypad.
  • monitoring device 1 executes a command for updating a protocol. Updating may involve changing the reference values that determine an abnormal condition or changing reference values that distinguish the severity of an abnormal condition, e.g. an emergency. Other updates include changing the sequence of steps or the responses in the response profile. In this step, additional protocols may be added. Protocols may be updated to reflect changing patient conditions, history or other factors.
  • monitoring device 1 executes a command to update a program.
  • a program may comprise modules including algorithms for processing signals from sensors. Modules may be updated to reflect newer modules with improved features. Additionally, modules may be updated to reflect the addition of external or additional sensors.
  • monitoring device 1 performs a function.
  • a function may include transmitting a communication signal, performing a treatment, or other functions specified in the response profile of the protocol.
  • the response profile may indicate which parameters to transmit, how much data (minutes, hours, days) to transmit, and how frequently to continue measuring.
  • monitoring device 1 stores measurement values. Values may be stored as a result of a protocol activated at step 712 or as a result of normal conditions. Step 720 may be performed, for example, once an abnormal condition has been detected so as to update a caregiver on a substantially real-time basis. Step 720 may also be performed at regular intervals, such as once a day, once a week, once a month, etc. Alternatively or in addition to these transmissions, computing device 20 may be programmed to respond to requests for data received by communication device 30 (e.g., from a health care provider) by causing communication device 30 to transmit the requested data or information representing the requested data.
  • communication device 30 e.g., from a health care provider

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Optical Measuring Cells (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
PCT/IB2009/006081 2008-05-12 2009-05-12 Method and system for monitoring a health condition Ceased WO2009138881A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2722616A CA2722616A1 (en) 2008-05-12 2009-05-12 Method and system for monitoring a health condition
EP09746176A EP2282667A4 (en) 2008-05-12 2009-05-12 METHOD AND SYSTEM FOR MONITORING HEALTH STATUS
CN2009801189249A CN102046069A (zh) 2008-05-12 2009-05-12 用于监视健康状况的方法和系统
JP2011509040A JP5650104B2 (ja) 2008-05-12 2009-05-12 健康状態を監視する装置およびシステム
IL209210A IL209210A (en) 2008-05-12 2010-11-09 System and method for monitoring health condition

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US12/119,462 2008-05-12
US12/119,325 US8298148B2 (en) 2005-12-08 2008-05-12 Integrated heart monitoring device and method of using same
US12/119,462 US9037208B2 (en) 2005-12-08 2008-05-12 Method and system for monitoring a health condition
US12/119,315 2008-05-12
US12/119,315 US8442606B2 (en) 2006-12-10 2008-05-12 Optical sensor apparatus and method of using same
US12/119,339 US20080287800A1 (en) 2006-12-10 2008-05-12 Doppler motion sensor apparatus and method of using same
US12/119,339 2008-05-12
US12/119,325 2008-05-12
US12/206,885 US20090048518A1 (en) 2006-12-10 2008-09-09 Doppler motion sensor apparatus and method of using same
US12/206,885 2008-09-09

Publications (3)

Publication Number Publication Date
WO2009138881A2 true WO2009138881A2 (en) 2009-11-19
WO2009138881A3 WO2009138881A3 (en) 2010-05-14
WO2009138881A4 WO2009138881A4 (en) 2010-07-15

Family

ID=41170098

Family Applications (4)

Application Number Title Priority Date Filing Date
PCT/IB2009/006081 Ceased WO2009138881A2 (en) 2008-05-12 2009-05-12 Method and system for monitoring a health condition
PCT/IB2009/006088 Ceased WO2009138883A2 (en) 2008-05-12 2009-05-12 Integrated heart monitoring device and method of using same
PCT/IB2009/006082 Ceased WO2009138882A2 (en) 2008-05-12 2009-05-12 Doppler motion sensor apparatus and method of using same
PCT/IB2009/006078 Ceased WO2009138880A2 (en) 2008-05-12 2009-05-12 Optical sensor apparatus and method of using same

Family Applications After (3)

Application Number Title Priority Date Filing Date
PCT/IB2009/006088 Ceased WO2009138883A2 (en) 2008-05-12 2009-05-12 Integrated heart monitoring device and method of using same
PCT/IB2009/006082 Ceased WO2009138882A2 (en) 2008-05-12 2009-05-12 Doppler motion sensor apparatus and method of using same
PCT/IB2009/006078 Ceased WO2009138880A2 (en) 2008-05-12 2009-05-12 Optical sensor apparatus and method of using same

Country Status (6)

Country Link
EP (4) EP2282667A4 (enExample)
JP (4) JP5591794B2 (enExample)
CN (4) CN102046069A (enExample)
CA (4) CA2722659A1 (enExample)
IL (4) IL209211A (enExample)
WO (4) WO2009138881A2 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012017821A1 (ja) * 2010-08-06 2012-02-09 株式会社 日立メディコ 医用画像診断装置及び心臓計測値表示方法
WO2016176117A1 (en) * 2015-04-28 2016-11-03 Therabionic Llc Hemodynamic parameter (hdp) monitoring system for diagnosis of a health condition of a patient
JP2018502612A (ja) * 2014-11-13 2018-02-01 ヴァンダービルト ユニバーシティー 出血検出および誘導蘇生のための装置と方法およびその用途
US10964393B2 (en) 2014-05-22 2021-03-30 Semiconductor Energy Laboratory Co., Ltd. Method for operating a semiconductor device having a memory circuit with an OS transistor and an arithmetic circuit
US11464440B2 (en) 2019-04-10 2022-10-11 Autem Medical, Llc System for prognosticating patient outcomes and methods of using the same

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102755151A (zh) * 2011-04-27 2012-10-31 深圳市迈迪加科技发展有限公司 一种心脏功能监测方法
CN102755152A (zh) * 2011-04-27 2012-10-31 深圳市迈迪加科技发展有限公司 一种心脏功能监测仪器
CN102293643B (zh) * 2011-05-23 2014-07-02 陕西鸿远科技有限公司 一种植入式生理数据测量装置
EP2526856A1 (en) * 2011-05-26 2012-11-28 Koninklijke Philips Electronics N.V. Fever detection apparatus
WO2013059832A1 (en) * 2011-10-21 2013-04-25 Incube Labs, Llc Implantable oximetric measurement apparatus and method of use
CN102564857B (zh) * 2012-01-18 2015-07-29 复旦大学 血管非线性力学性质测量装置
WO2013161075A1 (ja) * 2012-04-27 2013-10-31 パイオニア株式会社 体調監視装置及び方法
WO2013161074A1 (ja) * 2012-04-27 2013-10-31 パイオニア株式会社 体調監視装置及び方法
JP2013252423A (ja) * 2012-05-08 2013-12-19 Seiko Epson Corp 心拍出量モニター装置および心拍出量測定方法
AU2013285103B2 (en) * 2012-07-05 2016-05-12 Microtech Medical Technologies Ltd. Direct deployment system and method
EP2882355A1 (en) 2012-08-13 2015-06-17 Mor Research Applications Ltd. Radial artery device
CA2923230C (en) * 2012-09-17 2022-08-09 Donald A. Rhodes Technique for determining optimum treatment parameters
HK1216705A1 (zh) * 2013-01-28 2016-12-02 Valencell, Inc. 具有與身體運動脫開的感測元件的生理監測裝置
WO2014141379A1 (ja) 2013-03-12 2014-09-18 富士通株式会社 無線通信システム、無線通信方法、送信装置、制御方法、及び、制御プログラム
US9636070B2 (en) * 2013-03-14 2017-05-02 DePuy Synthes Products, Inc. Methods, systems, and devices for monitoring and displaying medical parameters for a patient
CN103932737A (zh) * 2014-04-28 2014-07-23 刘树英 一种心血管血液流速传感器
CN104013389B (zh) * 2014-06-18 2016-01-20 香港应用科技研究院有限公司 用于搜索动脉位置的方法和设备
US10905393B2 (en) * 2015-02-12 2021-02-02 Foundry Innovation & Research 1, Ltd. Implantable devices and related methods for heart failure monitoring
US9696199B2 (en) 2015-02-13 2017-07-04 Taiwan Biophotonic Corporation Optical sensor
JP6865695B2 (ja) * 2015-06-10 2021-04-28 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. 超音波撮像装置
KR101653502B1 (ko) * 2015-06-12 2016-09-09 한국 한의학 연구원 미병 분류를 보조하는 컴퓨팅 장치 및 방법
US11207054B2 (en) 2015-06-19 2021-12-28 Novasignal Corp. Transcranial doppler probe
EP3397139B1 (en) * 2015-12-31 2024-01-31 Wear2b Ltd Device, system and method for non-invasive monitoring of physiological measurements
CN108778141A (zh) 2016-01-05 2018-11-09 神经系统分析公司 集成化探针结构
CN108778140A (zh) * 2016-01-05 2018-11-09 神经系统分析公司 用于确定临床指征的系统和方法
US11589836B2 (en) 2016-01-05 2023-02-28 Novasignal Corp. Systems and methods for detecting neurological conditions
CN108778107B (zh) * 2016-03-04 2021-08-03 皇家飞利浦有限公司 用于脉管表征的装置
CN106073754A (zh) * 2016-05-16 2016-11-09 天津工业大学 一种低功耗的便携式心电监测装置
CN105994004A (zh) * 2016-05-19 2016-10-12 上海应特宠企业管理有限公司 宠物实时监测系统
CN106037643A (zh) * 2016-05-19 2016-10-26 上海应特宠企业管理有限公司 持续检测哺乳动物体征的植入芯片及系统
JP7103644B2 (ja) * 2016-05-31 2022-07-20 国立大学法人九州大学 流量測定装置、流量測定方法、圧力測定装置、及び圧力測定方法
US10182729B2 (en) * 2016-08-31 2019-01-22 Medtronics, Inc. Systems and methods for monitoring hemodynamic status
CN108332780B (zh) * 2017-01-10 2020-11-10 派克汉尼芬公司 光学供电的传感器校准数据存储模块
US12004846B2 (en) 2018-04-10 2024-06-11 Cerenetex, Inc. Non-invasive systems and methods for the improved evaluation of patients suffering from undiagnosed headaches
EP3773175A4 (en) 2018-04-10 2022-05-18 Cerenetex, Inc. SYSTEMS AND METHODS FOR IDENTIFYING MEDICAL CONDITIONS AND DETERMINING RELEVANT THERAPY BY PASSIVELY DETECTING ACOUSTIC SIGNALS GENERATED BY THE BRAIN VESSELS
CN112638242A (zh) * 2018-08-24 2021-04-09 马塞洛·马利尼·拉梅戈 监测设备及系统
CN109431485A (zh) * 2018-11-06 2019-03-08 天津大学 一种应用于球囊导管中的血液流速检测装置
AU2019384549B2 (en) * 2018-11-20 2024-09-19 Veris Health Inc. Vascular access devices for monitoring patient health
CN110339427B (zh) * 2019-05-30 2021-12-14 努比亚技术有限公司 一种输液监测方法、可穿戴设备及计算机可读存储介质
CN110384495B (zh) * 2019-06-18 2021-06-04 华为技术有限公司 一种ecg检测方法与穿戴设备
CN110495864B (zh) * 2019-08-02 2022-04-05 深圳市德胜医疗科技有限公司 人体血管血流收缩力与舒张力测定方法及装置
JP6787607B1 (ja) * 2019-08-27 2020-11-18 橋本電子工業株式会社 超音波式血流情報判別装置
EP4039173A1 (en) * 2021-02-04 2022-08-10 Ecole Polytechnique Fédérale de Lausanne (EPFL) Cardiovascular monitoring system
CN117119966A (zh) * 2021-04-19 2023-11-24 静脉科技有限公司 用于超声成像的便携式超声装置和方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
JP2006204432A (ja) 2005-01-26 2006-08-10 Seiko Instruments Inc 生体情報測定装置
WO2007066343A2 (en) 2005-12-08 2007-06-14 Dan Furman Implantable biosensor assembly and health monitoring system

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770177A (en) * 1986-02-18 1988-09-13 Telectronics N.V. Apparatus and method for adjusting heart/pacer relative to changes in venous diameter during exercise to obtain a required cardiac output.
US5115133A (en) * 1990-04-19 1992-05-19 Inomet, Inc. Testing of body fluid constituents through measuring light reflected from tympanic membrane
US5218962A (en) 1991-04-15 1993-06-15 Nellcor Incorporated Multiple region pulse oximetry probe and oximeter
CA2103166C (en) * 1991-05-16 2003-10-28 Britton Chance Lateralization spectrophotometer
US5370114A (en) 1992-03-12 1994-12-06 Wong; Jacob Y. Non-invasive blood chemistry measurement by stimulated infrared relaxation emission
US5544649A (en) * 1992-03-25 1996-08-13 Cardiomedix, Inc. Ambulatory patient health monitoring techniques utilizing interactive visual communication
US5558092A (en) * 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5995860A (en) * 1995-07-06 1999-11-30 Thomas Jefferson University Implantable sensor and system for measurement and control of blood constituent levels
US5606972A (en) * 1995-08-10 1997-03-04 Advanced Technology Laboratories, Inc. Ultrasonic doppler measurement of blood flow velocities by array transducers
US6511426B1 (en) * 1998-06-02 2003-01-28 Acuson Corporation Medical diagnostic ultrasound system and method for versatile processing
JP2003509098A (ja) * 1999-09-17 2003-03-11 エンドルミナル セラピューティクス, インコーポレイテッド 医用移植片のセンシング、インタロゲーティング、記憶、遠隔機器を用いた通信、測定および応答
JP2001087249A (ja) * 1999-09-27 2001-04-03 Sanyo Electric Co Ltd 血液成分測定装置
JP4607308B2 (ja) * 2000-10-03 2011-01-05 シスメックス株式会社 非侵襲生体計測装置とその方法
US20060100530A1 (en) * 2000-11-28 2006-05-11 Allez Physionix Limited Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters
JP2002172095A (ja) * 2000-12-06 2002-06-18 K & S:Kk 脈波測定装置
DE60207183T2 (de) * 2001-12-10 2006-08-10 Kabushiki Gaisha K-And-S Vorrichtung zur Beobachtung biologischer Daten
US6985771B2 (en) * 2002-01-22 2006-01-10 Angel Medical Systems, Inc. Rapid response system for the detection and treatment of cardiac events
JP2003218805A (ja) * 2002-01-25 2003-07-31 Tama Tlo Kk 超音波を利用した電力および信号伝送装置
US6609023B1 (en) * 2002-09-20 2003-08-19 Angel Medical Systems, Inc. System for the detection of cardiac events
WO2004033036A2 (en) * 2002-10-04 2004-04-22 Microchips, Inc. Medical device for controlled drug delivery and cardiac monitoring and/or stimulation
US7010337B2 (en) * 2002-10-24 2006-03-07 Furnary Anthony P Method and apparatus for monitoring blood condition and cardiopulmonary function
JP2004148070A (ja) * 2002-10-29 2004-05-27 Tse:Kk 血中多成分検出装置
US6931328B2 (en) * 2002-11-08 2005-08-16 Optiscan Biomedical Corp. Analyte detection system with software download capabilities
US7035684B2 (en) * 2003-02-26 2006-04-25 Medtronic, Inc. Method and apparatus for monitoring heart function in a subcutaneously implanted device
US6944488B2 (en) * 2003-04-30 2005-09-13 Medtronic, Inc. Normalization method for a chronically implanted optical sensor
US7303530B2 (en) * 2003-05-22 2007-12-04 Siemens Medical Solutions Usa, Inc. Transducer arrays with an integrated sensor and methods of use
JP4272024B2 (ja) * 2003-09-16 2009-06-03 浜松ホトニクス株式会社 光生体計測装置
JP4412644B2 (ja) * 2003-10-29 2010-02-10 セイコーインスツル株式会社 循環動態測定装置
JP4460316B2 (ja) * 2004-01-27 2010-05-12 日本電信電話株式会社 生体情報計測装置及び健康管理システム
US7637871B2 (en) * 2004-02-26 2009-12-29 Siemens Medical Solutions Usa, Inc. Steered continuous wave doppler methods and systems for two-dimensional ultrasound transducer arrays
JP2006026394A (ja) * 2004-06-15 2006-02-02 Sysmex Corp 非侵襲生体計測装置
US20060129038A1 (en) * 2004-12-14 2006-06-15 Zelenchuk Alex R Optical determination of in vivo properties
JP4767551B2 (ja) 2005-02-14 2011-09-07 セイコーインスツル株式会社 血液レオロジー測定装置および血液レオロジー計測方法
US7747301B2 (en) 2005-03-30 2010-06-29 Skyline Biomedical, Inc. Apparatus and method for non-invasive and minimally-invasive sensing of parameters relating to blood
WO2006123282A1 (en) * 2005-05-18 2006-11-23 Koninklijke Philips Electronics N.V. Cannula inserting system
JP2006325766A (ja) * 2005-05-24 2006-12-07 Sharp Corp 生体信号測定装置
JP2007020735A (ja) * 2005-07-13 2007-02-01 Toshiba Corp 生体光計測装置
CN100445488C (zh) * 2005-08-01 2008-12-24 邱则有 一种现浇砼成型用空腔构件
US20070088214A1 (en) * 2005-10-14 2007-04-19 Cardiac Pacemakers Inc. Implantable physiologic monitoring system
US20070142727A1 (en) * 2005-12-15 2007-06-21 Cardiac Pacemakers, Inc. System and method for analyzing cardiovascular pressure measurements made within a human body
US8078278B2 (en) * 2006-01-10 2011-12-13 Remon Medical Technologies Ltd. Body attachable unit in wireless communication with implantable devices
GB0607270D0 (en) * 2006-04-11 2006-05-17 Univ Nottingham The pulsing blood supply
US7559899B2 (en) * 2006-04-12 2009-07-14 Salutron, Inc. Power saving techniques for continuous heart rate monitoring
US7539532B2 (en) * 2006-05-12 2009-05-26 Bao Tran Cuffless blood pressure monitoring appliance
TW200744529A (en) * 2006-06-09 2007-12-16 Avita Corp Medical measuring device with long distant transmission function

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
JP2006204432A (ja) 2005-01-26 2006-08-10 Seiko Instruments Inc 生体情報測定装置
WO2007066343A2 (en) 2005-12-08 2007-06-14 Dan Furman Implantable biosensor assembly and health monitoring system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2282667A4

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012017821A1 (ja) * 2010-08-06 2012-02-09 株式会社 日立メディコ 医用画像診断装置及び心臓計測値表示方法
JPWO2012017821A1 (ja) * 2010-08-06 2013-10-03 株式会社日立メディコ 医用画像診断装置及び心臓計測値表示方法
US10964393B2 (en) 2014-05-22 2021-03-30 Semiconductor Energy Laboratory Co., Ltd. Method for operating a semiconductor device having a memory circuit with an OS transistor and an arithmetic circuit
US11488668B2 (en) 2014-05-22 2022-11-01 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and healthcare system
JP2018502612A (ja) * 2014-11-13 2018-02-01 ヴァンダービルト ユニバーシティー 出血検出および誘導蘇生のための装置と方法およびその用途
WO2016176117A1 (en) * 2015-04-28 2016-11-03 Therabionic Llc Hemodynamic parameter (hdp) monitoring system for diagnosis of a health condition of a patient
US10624546B2 (en) 2015-04-28 2020-04-21 Therabionic Llc Hemodynamic parameter (Hdp) monitoring system for diagnosis of a health condition of a patient
US11589765B2 (en) 2015-04-28 2023-02-28 Therabionic, Inc. Hemodynamic parameter (HDP) monitoring system for diagnosis of a health condition of a patient
US12458242B2 (en) 2015-04-28 2025-11-04 Therabionic, Inc. Hemodynamic parameter (Hdp) monitoring system for diagnosis of a health condition of a patient
US11464440B2 (en) 2019-04-10 2022-10-11 Autem Medical, Llc System for prognosticating patient outcomes and methods of using the same

Also Published As

Publication number Publication date
CN102046085B (zh) 2013-12-25
EP2282671A4 (en) 2012-11-21
EP2282671A2 (en) 2011-02-16
WO2009138882A4 (en) 2010-05-27
CN102065773A (zh) 2011-05-18
WO2009138880A2 (en) 2009-11-19
JP2011521678A (ja) 2011-07-28
EP2285288A4 (en) 2012-11-28
EP2282667A4 (en) 2012-11-21
CN102202568A (zh) 2011-09-28
JP5650104B2 (ja) 2015-01-07
JP2011519703A (ja) 2011-07-14
WO2009138880A3 (en) 2010-01-07
IL209213A0 (en) 2011-01-31
JP5405564B2 (ja) 2014-02-05
JP5497008B2 (ja) 2014-05-21
IL209212A0 (en) 2011-01-31
JP5591794B2 (ja) 2014-09-17
CN102065773B (zh) 2014-04-09
IL209211A0 (en) 2011-01-31
IL209213A (en) 2014-06-30
CN102046085A (zh) 2011-05-04
CA2722616A1 (en) 2009-11-19
CA2722662A1 (en) 2009-11-19
IL209212A (en) 2014-06-30
WO2009138883A3 (en) 2011-09-01
CA2722659A1 (en) 2009-11-19
JP2011519704A (ja) 2011-07-14
WO2009138882A3 (en) 2010-04-08
WO2009138881A4 (en) 2010-07-15
IL209210A0 (en) 2011-01-31
CN102046069A (zh) 2011-05-04
WO2009138881A3 (en) 2010-05-14
IL209211A (en) 2014-06-30
JP2011526498A (ja) 2011-10-13
WO2009138882A2 (en) 2009-11-19
CA2722593A1 (en) 2009-11-19
WO2009138883A2 (en) 2009-11-19
EP2285288A2 (en) 2011-02-23
EP2282673A2 (en) 2011-02-16
IL209210A (en) 2014-06-30
EP2282667A2 (en) 2011-02-16

Similar Documents

Publication Publication Date Title
US9037208B2 (en) Method and system for monitoring a health condition
JP5650104B2 (ja) 健康状態を監視する装置およびシステム
US12403324B2 (en) Wearable medical device (WMD) implementing adaptive techniques to save power
US8712509B2 (en) Virtual physician acute myocardial infarction detection system and method
EP1006871B1 (en) Remote monitoring apparatus for medical conditions
US10111643B2 (en) Cardiac monitor system and method for home and telemedicine application
Leijdekkers et al. Personal heart monitoring and rehabilitation system using smart phones
US20020103508A1 (en) Remotely operated defibrillator
JP2005538784A (ja) 人の健康状態を監視するための構成
WO2002019897A2 (en) Cardiopulmonary monitoring
US12364428B2 (en) Triggering arrhythmia episodes for heart failure and chronotropic incompetence diagnosis and monitoring
CN101252877A (zh) 用于检测并预测晕厥事件的系统和方法
US10165980B2 (en) Toilet with a health monitoring torso belt
US8491485B2 (en) Electromedical implant and monitoring system including the electromedical implant
EP4069067B1 (en) Intervention for heart failure management
US12300368B1 (en) Analysis and presentation of aggregated patient and device data within a system that includes a medical device
AU730834B2 (en) Remote monitoring apparatus for medical conditions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980118924.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09746176

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2722616

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2011509040

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009746176

Country of ref document: EP